Plasma P‐tau181 is increased in Alzheimer’s disease (AD), and correlates with brain deposition of aggregated β‐amyloid (Aβ) and tau, the core AD hallmarks.1, 2, 3. Here, MAPT is linked to Alzheimer disease.